CMS has released their latest round of drug pricing data – another peek into the functionality of the prescription drug supply chain amid the COVID-19 pandemic. As we highlighted in the June and July NADAC reports, generic drug prices are weathering the pandemic storm. In fact, not only have the predictions of massive increases failed to come to fruition, but instead, generic drug prices are falling. This month continues that trend. Our latest report digs into the numbers using the latest NADAC drug pricing data from CMS.
Read More
CMS has released their latest round of drug pricing data – this one reflecting price changes from arguably the peak of COVID-19 hysteria and supply chain pressure. The release gives us long-anticipated insight into how the drug supply chain is operating as it is pushed up against the wall by unprecedented disruption. Surveys have shown that Americans believe that the pandemic will yield drug price increases from manufacturers, and given the growing number of shortages, who can blame them? Well, the CMS data shows that everyone may be in for a surprise: overall, generic drug prices don’t appear to be budging.
Read More
It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw less price increases than decreases this past month, and an overall decrease in annualized spending based on typical utilization trends. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for important updates on the latest generic drug price changes, plus an updated NADAC Packed Bubble Chart. Additionally, check out the interesting spike in hydrocodone-acetaminophen prices, which occurred just weeks after the major opioid lawsuit settlements.
Read More
It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” It looks like we saw a lot of price increases this past month, but overall decrease in annualized spending. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated and upgraded NADAC Packed Bubble Chart!
Read More
It’s NADAC survey results week, which means it’s time for our third installment of “what happened to generic drug prices last month.” It looks like there was a bit of net deflation, but overall, there were an equal number of price increases and decreases. But as always, the details matter. Check out our latest drug pricing report for a lot of important updates, plus an updated NADAC Packed Bubble Chart!
Read More
It’s NADAC survey results week, which means it’s time for our second installment of “what happened to generic drug prices last month.” Good news. Prices are dropping significantly. Check out our latest drug pricing report for lots of important updates, plus an updated NADAC Packed Bubble Chart!
Read More